Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library alemtuzumab

alemtuzumab

Pronunciation: AL em TOOZ ue mab

Brand: Campath, Lemtrada

What is the most important information I should know about alemtuzumab?

What is the most important information I should know about alemtuzumab?

Alemtuzumab can cause life-threatening side effects, including serious medical problems that may occur months to years after you receive this medicine.

What is alemtuzumab?

What is alemtuzumab?

Campath is used to treat B-cell chronic lymphocytic leukemia in adults.

Lemtrada is used to treat relapsing forms of multiple sclerosis in people 17 years and older (including active secondary progressive disease), after at least two other medicines did not work or have stopped working.

Lemtrada will not cure MS, but it can make relapses occur less often. Lemtrada is not for use in treating clinically isolated syndrome.

Alemtuzumab may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving alemtuzumab?

What should I discuss with my healthcare provider before receiving alemtuzumab?

You may not be able to use alemtuzumab if you are allergic to it, or if you have an active infection, o HIV (human immunodeficiency virus).

Tell your doctor if you have ever had:

  • tuberculosis or other infections;
  • a thyroid disorder;
  • kidney disease;
  • bleeding problems, or if you receive blood transfusions; or
  • if you have received any vaccine in the past 6 weeks.

Tell your doctor if you have never had chickenpox or if you have never received a varicella vaccine (Varivax). You may need to receive the vaccine and then wait 6 weeks before using Lemtrada.

Lemtrada may increase your risk of developing other types of cancer, such as melanoma, thyroid cancer, lymphoma, or leukemia. Ask your doctor about this risk.

You may need to have a negative pregnancy test before starting this treatment. Alemtuzumab may harm an unborn baby. Use effective birth control to prevent pregnancy while receiving this medicine, and for at least 3 months after your last dose of Campath and for 4 months after your last dose of Lemtrada. Tell your doctor if you become pregnant.

If you use Campath while you are pregnant, make sure any doctor caring for your new baby knows that you used the medicine during pregnancy. Being exposed to Campath in the womb could affect your baby's vaccination schedule.

Alemtuzumab may affect fertility (ability to have children) in both men and women. However, women should still use birth control to prevent pregnancy because alemtuzumab can harm an unborn baby.

It may not be safe to breastfeed while using alemtuzumab. You should not breastfeed while using Campath, and for at least 3 months after your last dose.

How is alemtuzumab given?

How is alemtuzumab given?

Alemtuzumab is given as an infusion into a vein. A healthcare provider will give you this injection. You will be watched closely for up to 2 hours or longer after the infusion, to make sure you do not have a serious reaction.

Campath is usually given 3 times per week for 12 weeks. Lemtrada is usually given in 2 or more treatment courses, separated by 1 year. Your doctor will determine how long to treat you and the number of courses you need. This medicine must be given slowly. The Campath infusion can take 2 hours to complete. The Lemtrada infusion can take 4 hours to complete.

You may be given other medicines to help prevent certain side effects or infections. Use these medicines for the full prescribed length of time.

Alemtuzumab affects your immune system. You may get infections more easily, even serious or fatal infections. You will need frequent medical tests, and your next dose may be delayed based on the results.

You should have a human papilloma virus (HPV) screening every year if you are a female.

Alemtuzumab can have long lasting effects on your body. You may need medical tests for up to 2 months after you stop using Campath, or 4 years after you stop using Lemtrada.

What happens if I miss a dose?

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your alemtuzumab injection.

What happens if I overdose?

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while receiving alemtuzumab?

What should I avoid while receiving alemtuzumab?

Do not receive a "live" vaccine while using alemtuzumab. The vaccine may not work as well or you could develop a serious infection. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

While being treated with Lemtrada, avoid foods that may be a source of Listeria infection, or heat them thoroughly before consuming. This includes deli meat, undercooked meat, seafood, poultry, unpasteurized dairy products, or soft cheeses.

What are the possible side effects of alemtuzumab?

What are the possible side effects of alemtuzumab?

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Get emergency medical help if you have symptoms of thrombotic thrombocytopenic purpura: purple spots on the skin or in the mouth, jaundice (yellowing of the skin or eyes), tiredness, fever, feeling short of breath, fast heart rate, speech or vision changes, confusion, seizure, dark or blood in your urine, stomach pain, nausea, vomiting, or diarrhea.

Alemtuzumab may cause a brain infection that can lead to disability or death. Tell your doctor if you have problems with speech, thought, vision, or muscle movement. These symptoms can get worse quickly.

Some side effects may occur during or shortly after the injection. Tell your caregiver if you feel weak, feverish, chilled, dizzy, nauseated, light-headed, or have a rash, wheezing, chest pain, trouble breathing, swelling in your mouth or throat, or fast, slow, or irregular heartbeats.

Alemtuzumab can cause your immune system to attack cells and organs in your body. This can lead to serious medical problems that may occur months to years after you receive Campath or Lemtrada. Call your doctor at once if you have:

  • unusual bleeding or bruising, nosebleeds, bleeding gums, heavy menstrual periods, blood in your urine or stools, coughing up blood, problems with speech, weakness on one side, neck pain, severe headache, drooping of your face;
  • a mole that has changed in size or color, cough, wheezing, chest pain, feeling short of breath, coughing up blood;
  • an overactive immune system --fever, swollen glands, rash, feeling unsteady or less alert, trouble waking, seizure;
  • liver problems --loss of appetite, stomach pain (upper right side), dark urine, jaundice (yellowing of the skin or eyes);
  • kidney problems --swelling in your lower legs, weight gain, loss of appetite, sudden pain in your stomach and back, urine that looks pink/brown or foamy;
  • signs of infection --fever, chills, sore throat, cough, mouth sores, skin sores or blisters, tingling, burning pain, pale or yellowed skin, pain or burning when you urinate, dark urine, feeling light-headed, cold hands and feet;
  • signs of tuberculosis --cough, night sweats, loss of appetite, weight loss, and feeling very tired;
  • signs of a stroke or tear in an artery --sudden severe headache, weakness on one side of your body, drooping in your face, slurred speech;
  • gallbladder problems --fever, nausea, vomiting, and stomach pain;
  • symptoms of Autoimmune encephalitis --personality or mood changes, hallucinations, agitation, confusion, short term memory loss, movement disorders;
  • symptoms of Adult onset Still's disease --high fever, pain, stiffness with or without swelling in multiple joints, rash;
  • thyroid problems --sweating, feeling cold, fast heartbeats, feeling nervous or tired, eye swelling, weight gain or loss, constipation; or
  • symptoms of thyroid cancer --a lump or swelling in your neck or throat, trouble swallowing, hoarse voice, or a new cough (not caused by a cold).

Common side effects may include:

  • reactions to the injection, rash, itching, tingling, hives;
  • stomach pain, nausea, vomiting, diarrhea;
  • infections (fever, chills, runny or stuffy nose, mouth or throat pain, painful urination);
  • chest pain or tightness, coughing up blood;
  • dizziness, tiredness, trouble sleeping;
  • headache, joint pain, back pain, pain in your arms or legs; or
  • thyroid problems, flushing (sudden warmth, redness, or tingly feeling).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect alemtuzumab?

What other drugs will affect alemtuzumab?

Tell your doctor about all your other medicines, especially drugs that weaken the immune system such as cancer medicine, or medicines to prevent organ transplant rejection.

Other drugs may affect alemtuzumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Where can I get more information?

Where can I get more information?

Your doctor or pharmacist can provide more information about alemtuzumab.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About The Cigna Group Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details